DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Gough SC, Bode B, Woo V. et al.
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.
Lancet Diabet Endocrinol 2014;
2 (11) 885-893
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.